China to Eliminate Cancer Drug Import Tariffs
China is one of the world’s largest markets for cancer treatment, with 2016 sales of anti-cancer drugs in the country at 102 billion yuan ($16.2 billion). Photo: VCG
Starting May 1, China will eliminate tariffs on cancer drugs, cutting costs for drug importers.
But whether the move will ease the financial burden on Chinese patients remains to be seen, especially since the value-added tax will drop only slightly.
The State Council, the country’s cabinet, decided during a Thursday meeting (link in Chinese) that anti-cancer drugs will be exempt from import tariffs.
You've accessed an article available only to subscribers
Try 4 weeks for $0.99
SUBSCRIBE
Share this article
Open WeChat and scan the QR code
RELATED
MOST POPULAR
- 1Update: China Demands Answers for Swedish Police’s ‘Brutal’ Treatment of Tourists
- 2Chinese Thesis Ghostwriting Scandal Reveals Huge Gray Market
- 3China Could Ban Exports of Products Crucial to U.S. Manufacturers, Former Finance Minister Says
- 4 State-Owned Firms to Build $6.5 Billion Petrochemical Refinery in Alberta
- 5Trump Slaps New Tariffs on $200 Billion of Chinese Goods
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas